For example, the expression of programmed cell death 1 ligand 1 (PD-L1) in cancer cells can drive the activation of Akt-mTOR and glycolysis in cancer cells, increase glucose uptake, and enhance the ability to compete with T cells for glucose [143]. Here, MTOR is linked to cancer.